Effectiveness and safety of preoperative carbohydrate loading in pediatric patients: A systematic review and

Zhenlong Yan1, Yanan Xu2, Rongxiong Dai1

  • 1Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

Insights

Preoperative carbohydrate loading (PCL) in pediatric patients improves anesthesia cooperation and reduces postoperative nausea and vomiting (PONV). Compound carbohydrate solutions offer a favorable metabolic safety profile, stabilizing insulin levels and reducing insulin resistance.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Metabolic Medicine

Background:

  • Preoperative fasting is standard for pediatric surgery, but can lead to metabolic stress and discomfort.
  • Preoperative carbohydrate loading (PCL) is an emerging strategy to mitigate fasting-related issues.
  • Evaluating PCL's impact on pediatric surgical outcomes is crucial for optimizing patient care.

Purpose of the Study:

  • To systematically evaluate the efficacy and safety of PCL in pediatric patients undergoing surgery.
  • To assess PCL's effects on behavioral indices, metabolic parameters, and postoperative nausea and vomiting (PONV).
  • To compare the metabolic profiles of standard versus compound carbohydrate solutions in PCL.

Main Methods:

  • A meta-analysis adhering to PRISMA 2020 guidelines was conducted.
  • Searched nine databases for randomized controlled trials (RCTs) of PCL in patients ≤18 years.
  • Analyzed outcomes including anxiety, sedation, mask acceptance, blood glucose, insulin, insulin resistance, and PONV.

Main Results:

  • PCL significantly improved cooperation during anesthesia induction, reducing anxiety and enhancing sedation.
  • PCL stabilized metabolic status, with compound solutions reducing postoperative insulin and insulin resistance.
  • PCL markedly reduced PONV incidence, particularly moderate-to-severe episodes.

Conclusions:

  • Preoperative carbohydrate loading offers multifaceted benefits in pediatric surgery.
  • Compound carbohydrate solutions present a favorable metabolic safety profile compared to standard solutions.
  • Tailoring PCL based on solution type is recommended for clinical application.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
702
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
733
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
372
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
461
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
424